Stop the war!

Остановите войну!

for scientists:

default search action

combined dblp search
author search
venue search
publication search

ask others

Yves Moreau

Name: dblp XML data dump
Creator: Schloss Dagstuhl - Leibniz Center for Informatics
Published: 1993
License: https://creativecommons.org/publicdomain/zero/1.0/
Keywords: dblp, XML, computer science, scholarly publications, metadata

◀ ▶ joint publications with Geert Fannes

> Home > Persons > Yves Moreau

Publications

2004
[j13]
- view
  authority control:
- export record
  dblp key:
  - journals/artmed/AntalFTMM04
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/artmed/AntalFTMM04
Peter Antal, Geert Fannes, Dirk Timmerman, Yves Moreau, Bart De Moor:
Using literature and data to learn Bayesian networks as clinical models of ovarian tumors. Artif. Intell. Medicine 30(3): 257-281 (2004)
2003
[j10]
- view
  authority control:
- export record
  dblp key:
  - journals/artmed/AntalFTMM03
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/artmed/AntalFTMM03
Peter Antal, Geert Fannes, Dirk Timmerman, Yves Moreau, Bart De Moor:
Bayesian applications of belief networks and multilayer perceptrons for ovarian tumor classification with rejection. Artif. Intell. Medicine 29(1-2): 39-60 (2003)
2001
[c8]
- view
  authority control:
- export record
  dblp key:
  - conf/aime/AntalFMVMT01
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/aime/AntalFMVMT01
Peter Antal, Geert Fannes, Bart De Moor, Joos Vandewalle, Yves Moreau, Dirk Timmerman:
Extended Bayesian Regression Models: A Symbiotic Application of Belief Networks and Multilayer Perceptrons for the Classification of Ovarian Tumors. AIME 2001: 177-187

a service of

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.